Your browser doesn't support javascript.
loading
Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
Farrington, Caroline C; Yuan, Eric; Mazhar, Sahar; Izadmehr, Sudeh; Hurst, Lauren; Allen-Petersen, Brittany L; Janghorban, Mahnaz; Chung, Eric; Wolczanski, Grace; Galsky, Matthew; Sears, Rosalie; Sangodkar, Jaya; Narla, Goutham.
Afiliación
  • Farrington CC; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio 44106.
  • Yuan E; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106.
  • Mazhar S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106.
  • Izadmehr S; Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
  • Hurst L; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48105.
  • Allen-Petersen BL; Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon 97239.
  • Janghorban M; Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon 97239.
  • Chung E; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106.
  • Wolczanski G; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48105.
  • Galsky M; Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
  • Sears R; Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon 97239.
  • Sangodkar J; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48105.
  • Narla G; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48105 gnarla@med.umich.edu.
J Biol Chem ; 295(3): 757-770, 2020 01 17.
Article en En | MEDLINE | ID: mdl-31822503
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Proteínas Proto-Oncogénicas c-myc / Proteínas Supresoras de Tumor / Proteína Fosfatasa 2 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Proteínas Proto-Oncogénicas c-myc / Proteínas Supresoras de Tumor / Proteína Fosfatasa 2 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2020 Tipo del documento: Article